We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Facing rocketing healthcare costs, a group of Florida entrepreneurs
is lobbying Capitol Hill this week to win support for Small Business Health Plans -- legislation that would allow small companies to band together across state lines to purchase health insurance.
Dr Reddy's Laboratories Ltd said on Wednesday it had launched in the United States the generic version of Merck & Co Ltd's Proscar drug for enlarged prostrates.
Newly-formed Sentry Logistic Solutions has built its first bridge, forming a partnership with BioStorage Technologies to offer global biopharma companies the first cold chain storage/logistics service
that spans all phases of drug development.
Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) goal date of August 2, 2006 for MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution).
SuperGen, Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Jefferies Life Sciences Conference, being held at the Mandarin Oriental in New York City on Wednesday, June 28, 2006 at 1:15 p.m. EDT. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress.
Affymetrix Inc. and Invitrogen Corporation announced today that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow Invitrogen to manufacture and sell spotted nucleic acid microarrays in the research field.
Barr Laboratories will pay $22.5 million to Sandoz to settle a lawsuit that alleged Barr unlawfully blocked access to the raw material source for warfarin sodium, Barr said June 12, the day the trial was to start.
The FDA has granted fast-track designation to two cancer treatments -- Genitope's MyVax for follicular non-Hodgkin's lymphoma and Bayer and Onyx's Nexavar for metastatic hepatocellular carcinoma,
or liver cancer.
Everyone involved with clinical trials, including sponsors, sites and investigators, faces a complex landscape of criminal and civil legal risks, according to experts speaking at a recent industry conference.